|
Korzeniowski et al. 2016 [16]
|
Informative and useful for patient communication as judged by clinicians
|
|
Sharma et al. 2016 [17]
|
Good feasibility both on paper and electronically
|
|
Skolarus et al. 2012 [18]
|
Good feasibility both on paper and automatic telephone response
|
|
Sampurno et al. 2015 [19]
|
Good feasibility both on paper and interactive voice method
|
|
Fosså et al. 2016 [20]
|
Internal consistencies alpha 0.64–0.91 of the 5 domains
|
|
Skolarus et al. 2012 [18]
|
Good test-retest reliability
|
|
Sampurno et al. 2015 [19]
|
Good test-retest reliability
|
|
Ellison et al. 2013 [21]
|
Criterion validity with the Incontinence Severity Index
|
|
Fosså et al. 2016 [20]
|
Criterion validity with the International Prostate Symptom Score
|
|
Punnen et al. 2013 [22]
|
Convergent validity of urinary and sexual bother scores and Generalized Anxiety Disorders Screener (GAD-7) and Distress Thermometer, and sexual bother with Patient Health Questionnaire-9 (depression)
|
|
Evans et al. 2015 [23]
|
Convergent validity with the SF-12 (quality of life)
|
|
Watson et al. 2015 [24]
|
Convergent validity of urine and bowel domains with health (EQ-5D-5 L), unmet needs (SCNS-SF34), anxiety/depression (HADS), and self-efficacy (Cancer Survivors Self Efficacy Scale)
|
|
Schofield et al. 2012 [25]
|
Divergent validity with unmet needs (SCNF-SF 34)
|
|
Evans et al. 2015 [23]
|
Predictive validity with the SF-12 (quality of life)
|
|
Recklitis et al. 2014 [26]
|
Predictive validity of hormonal subscale score and more suicidal ideation
|
|
Evans et al. 2015 [23]
|
Responsiveness to change (minimally important differences)
|
|
Skolarus et al. 2015 [27]
|
Responsiveness to change (minimally important differences)
|
|
Tavlarides et al. 2015 [28]
|
Responsiveness to change documented
|
|
Fosså et al. 2016 [20]
|
Responsiveness to change documented
|
